Related references
Note: Only part of the references are listed.The C-terminal tail of α-synuclein protects against aggregate replication but is critical for oligomerization
Azad Farzadfard et al.
COMMUNICATIONS BIOLOGY (2022)
Novel conformation-selective monoclonal antibodies against apoA-I amyloid fibrils
Takashi Ohgita et al.
FEBS JOURNAL (2021)
In situ kinetic measurements of α-synuclein aggregation reveal large population of short-lived oligomers
Enrico Zurlo et al.
PLOS ONE (2021)
The role of water in the primary nucleation of protein amyloid aggregation
Jose D. Camino et al.
BIOPHYSICAL CHEMISTRY (2021)
Mechanism of Secondary Nucleation at the Single Fibril Level from Direct Observations of Aβ42 Aggregation
Manuela R. Zimmermann et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Structural insights into α-synuclein monomer-fibril interactions
Pratibha Kumari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Role of α-Synuclein Regions in Nucleation and Elongation of Amyloid Fiber Assembly
Jose Gallardo et al.
ACS CHEMICAL NEUROSCIENCE (2020)
A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research
Senthil T. Kumar et al.
JOURNAL OF NEUROCHEMISTRY (2020)
Regulation of α-synuclein by chaperones in mammalian cells
Bjorn M. Burmann et al.
NATURE (2020)
New insights on the structure of alpha-synuclein fibrils using cryo-electron microscopy
Ricardo Guerrero-Ferreira et al.
CURRENT OPINION IN NEUROBIOLOGY (2020)
The emerging role of ?-synuclein truncation in aggregation and disease
Zachary A. Sorrentino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
A short motif in the N-terminal region of α-synuclein is critical for both aggregation and function
Ciaran P. A. Doherty et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
α-Synuclein aggregation nucleates through liquid-liquid phase separation
Soumik Ray et al.
NATURE CHEMISTRY (2020)
Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity
Amberley D. Stephens et al.
NATURE COMMUNICATIONS (2020)
Transmission of α-synuclein seeds in neurodegenerative disease: recent developments
Richard J. Karpowicz et al.
LABORATORY INVESTIGATION (2019)
Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice
Jessica M. Froula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
C-terminal -synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease
Ryan P. McGlinchey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I
Chiharu Mizuguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations
Xiaodan Ni et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
The physiological role of α-synuclein and its relationship to Parkinson's Disease
David Sulzer et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Alpha-synuclein structure and Parkinson's disease - lessons and emerging principles
Richard M. Meade et al.
MOLECULAR NEURODEGENERATION (2019)
Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes
Sarah H. Shahmoradian et al.
NATURE NEUROSCIENCE (2019)
α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities
Parvez Alam et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Parkinson's disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein
Katsuya Araki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease
Zachary A. Sorrentino et al.
ACTA NEUROPATHOLOGICA (2019)
Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let's talk about the lipids in the room
Bryan A. Killinger et al.
NPJ PARKINSONS DISEASE (2019)
Secondary nucleation in amyloid formation
Mattias Tornquist et al.
CHEMICAL COMMUNICATIONS (2018)
The effect of truncation on prion-like properties of -synuclein
Makoto Terada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Distinct thermodynamic signatures of oligomer generation in the aggregation of the amyloid-beta peptide
Samuel I. A. Cohen et al.
NATURE CHEMISTRY (2018)
C-terminal truncation of alpha-synuclein promotes amyloid fibril amplification at physiological pH
Ingrid M. van der Wateren et al.
CHEMICAL SCIENCE (2018)
Cryo-EM structure of alpha-synuclein fibrils
Ricardo Guerrero-Ferreira et al.
ELIFE (2018)
Amyloid fibril structure of α-synuclein determined by cryoelectron microscopy
Yaowang Li et al.
CELL RESEARCH (2018)
Targeting Amyloid Aggregation: An Overview of Strategies and Mechanisms
Sofia Giorgetti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
SAR by kinetics for drug discovery in protein misfolding diseases
Sean Chia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel
Binsen Li et al.
NATURE COMMUNICATIONS (2018)
Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions
Zachary A. Sorrentino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
α-Synuclein Aggregation Monitored by Thioflavin T Fluorescence Assay
Michael M. Woerdehoff et al.
BIO-PROTOCOL (2018)
Therapeutic approaches to target alpha-synuclein pathology
Patrik Brundin et al.
EXPERIMENTAL NEUROLOGY (2017)
α-synuclein aggregation and its modulation
Dhiman Ghosh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Sigmoidal Nucleation and Growth Curves Across Nature Fit by the Finke-Watzky Model of Slow Continuous Nucleation and Autocatalytic Growth: Explicit Formulas for the Lag and Growth Times Plus Other Key Insights
Lucian Bentea et al.
JOURNAL OF PHYSICAL CHEMISTRY C (2017)
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Yvette C. Wong et al.
NATURE MEDICINE (2017)
Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease
Zhentao Zhang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Scaling behaviour and rate-determining steps in filamentous self-assembly
Georg Meisl et al.
CHEMICAL SCIENCE (2017)
Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease
Zhentao Zhang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
ThT 101: a primer on the use of thioflavin T to investigate amyloid formation
Kirsten Gade Malmos et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2017)
Modification of C Terminus Provides New Insights into the Mechanism of α-Synuclein Aggregation
Kseniia Afitska et al.
BIOPHYSICAL JOURNAL (2017)
Perturbation in Long-Range Contacts Modulates the Kinetics of Amyloid Formation in α-Synuclein Familial Mutants
Priyatosh Ranjan et al.
ACS CHEMICAL NEUROSCIENCE (2017)
More than a Rumor Spreads in Parkinson's Disease
Natalia C. Prymaczok et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2016)
Therapeutic approaches in Parkinson's disease andrelated disorders
Elvira Valera et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Physical determinants of the self-replication of protein fibrils
Andela Saric et al.
NATURE PHYSICS (2016)
Molecular mechanisms of protein aggregation from global fitting of kinetic models
Georg Meisl et al.
NATURE PROTOCOLS (2016)
Estimation of the lag time in a subsequent monomer addition model for fibril elongation
Suzanne K. Shoffner et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2016)
Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation
Patrick Flagmeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Versatile Structures of α-Synuclein
Chuchu Wang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Alpha-Synuclein Oligomers-Neurotoxic Moleculesin Parkinson's Disease and Other Lewy Body Disorders
Martin Ingelsson
FRONTIERS IN NEUROSCIENCE (2016)
Structure of the toxic core of α-synuclein from invisible crystals
Jose A. Rodriguez et al.
NATURE (2015)
Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation
Alexander K. Buell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Chemical kinetics for drug discovery to combat protein aggregation diseases
Paolo Arosio et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation
Diana F. Lazaro et al.
PLOS GENETICS (2014)
α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?
Aoife P. Kiely et al.
ACTA NEUROPATHOLOGICA (2013)
Membrane bound α-synuclein is fully embedded in the lipid bilayer while segments with higher flexibility remain
Jonas Wietek et al.
FEBS LETTERS (2013)
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
Silke Appel-Cresswell et al.
MOVEMENT DISORDERS (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease
Dorota Hoffman-Zacharska et al.
PARKINSONISM & RELATED DISORDERS (2013)
Update on novel familial forms of Parkinson's disease and multiple system atrophy
Shinsuke Fujioka et al.
PARKINSONISM & RELATED DISORDERS (2013)
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Samuel I. A. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mutant Protein A30P α-Synuclein Adopts Wild-type Fibril Structure, Despite Slower Fibrillation Kinetics
Luisel R. Lemkau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
α-Synuclein in Parkinson's Disease
Leonidas Stefanis
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Early Aggregation Steps in α-Synuclein as Measured by FCS and FRET: Evidence for a Contagious Conformational Change
Sangeeta Nath et al.
BIOPHYSICAL JOURNAL (2010)
Protein aggregation kinetics, mechanism, and curve-fitting: A review of the literature
Aimee M. Morris et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
α-Synuclein aggregation variable temperature and variable pH kinetic data: A re-analysis using the Finke-Watzky 2-step model of nucleation and autocatalytic growth
Aimee M. Morris et al.
BIOPHYSICAL CHEMISTRY (2009)
Fitting neurological protein aggregation kinetic data via a 2-step, Minimal/Ockham's Razor model: The Finke-Watzky mechanism of nucleation followed by autocatalytic surface growt
Aimee M. Morris et al.
BIOCHEMISTRY (2008)
Observation of multiple intermediates in α-synuclein fibril formation by singular value decomposition analysis
Tomoaki Kamiyoshihara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Aggregated α-synuclein mediates dopaminergic neurotoxicity in vivo
Magali Periquet et al.
JOURNAL OF NEUROSCIENCE (2007)
Familial mutants of α-synuclein with increased neurotoxicity have a destabilized conformation
CW Bertoncini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
WX Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
α-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils
HA Lashuel et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Conformational behavior of human α-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T
J Li et al.
NEUROTOXICOLOGY (2002)
Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein
BI Giasson et al.
NEURON (2002)
Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from α-synuclein in vitro
JA Cohlberg et al.
BIOCHEMISTRY (2002)
Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human α-synuclein
J Li et al.
BIOCHEMISTRY (2001)
Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular mechanism
L Nielsen et al.
BIOCHEMISTRY (2001)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
